Healthcare provider profile · identity verified

Marisa Modini Bochman, MD

Family Practice · IPSWICH, MA · NPI 1366495749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	797	206
Lisinopril	Lisinopril	573	137
Amlodipine Besylate	Amlodipine Besylate	311	83
Levothyroxine Sodium	Levothyroxine Sodium	288	71
Hydrochlorothiazide	Hydrochlorothiazide	236	71
Omeprazole	Omeprazole	235	58
Losartan Potassium	Losartan Potassium	204	56
Metoprolol Succinate	Metoprolol Succinate	200	57
Escitalopram Oxalate	Escitalopram Oxalate	181	59
Trazodone Hcl	Trazodone Hcl	133	43
Eliquis	Apixaban	123	24
Atenolol	Atenolol	122	29
Sertraline Hcl	Sertraline Hcl	122	32
Alendronate Sodium	Alendronate Sodium	121	31
Albuterol Sulfate Hfa	Albuterol Sulfate	108	45
Gabapentin	Gabapentin	108	30
Alprazolam	Alprazolam	100	25
Lorazepam	Lorazepam	99	46
Famotidine	Famotidine	92	32
Fluoxetine Hcl	Fluoxetine Hcl	92	22
Tramadol Hcl	Tramadol Hcl	87	26
Allopurinol	Allopurinol	82	20
Rosuvastatin Calcium	Rosuvastatin Calcium	82	22
Furosemide	Furosemide	81	25
Metformin Hcl Er	Metformin Hcl	80	20
Pravastatin Sodium	Pravastatin Sodium	73	28
Prednisone	Prednisone	71	45
Clonazepam	Clonazepam	64	12
Ozempic	Semaglutide	63	suppressed
Synthroid	Levothyroxine Sodium	63	14
Simvastatin	Simvastatin	62	18
Montelukast Sodium	Montelukast Sodium	61	13
Pantoprazole Sodium	Pantoprazole Sodium	56	18
Bupropion Xl	Bupropion Hcl	54	16
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	19
Metformin Hcl	Metformin Hcl	48	12
Valsartan	Valsartan	48	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	19
Chlorthalidone	Chlorthalidone	42	12
Citalopram Hbr	Citalopram Hydrobromide	42	11
Zolpidem Tartrate	Zolpidem Tartrate	42	13
Doxycycline Hyclate	Doxycycline Hyclate	41	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	39	13
Mirtazapine	Mirtazapine	39	suppressed
Potassium Chloride	Potassium Chloride	39	suppressed
Estradiol	Estradiol	37	13
Doxazosin Mesylate	Doxazosin Mesylate	36	11
Methylphenidate Hcl	Methylphenidate Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Pregabalin	Pregabalin	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	12
Temazepam	Temazepam	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	22
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	16
Ipratropium Bromide	Ipratropium Bromide	20	14
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Metronidazole	Metronidazole	19	12
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Epinephrine	Epinephrine	15	13
Amoxicillin	Amoxicillin	14	12
Enalapril Maleate	Enalapril Maleate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Baclofen	Baclofen	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Crestor	Rosuvastatin Calcium	13	suppressed
Diazepam	Diazepam	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Finasteride	Finasteride	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Nystatin	Nystatin	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Climara Pro	Estradiol/Levonorgestrel	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error